502 related articles for article (PubMed ID: 25998899)
1. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition.
Izawa G; Kobayashi W; Haraguchi M; Sudo A; Ozawa M
Int J Mol Med; 2015 Jul; 36(1):166-72. PubMed ID: 25998899
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
Kobayashi W; Ozawa M
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
[TBL] [Abstract][Full Text] [Related]
3. Reversibility of the Snail-induced epithelial-mesenchymal transition revealed by the Cre-loxP system.
Ozawa M; Kobayashi W
Biochem Biophys Res Commun; 2015 Mar; 458(3):608-613. PubMed ID: 25681770
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor Snail enhanced the degradation of E-cadherin and desmoglein 2 in oral squamous cell carcinoma cells.
Kume K; Haraguchi M; Hijioka H; Ishida T; Miyawaki A; Nakamura N; Ozawa M
Biochem Biophys Res Commun; 2013 Jan; 430(3):889-94. PubMed ID: 23261431
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
[TBL] [Abstract][Full Text] [Related]
6. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT.
Díaz-López A; Díaz-Martín J; Moreno-Bueno G; Cuevas EP; Santos V; Olmeda D; Portillo F; Palacios J; Cano A
Int J Cancer; 2015 Feb; 136(4):E62-73. PubMed ID: 25178837
[TBL] [Abstract][Full Text] [Related]
7. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas.
Yokoyama K; Kamata N; Fujimoto R; Tsutsumi S; Tomonari M; Taki M; Hosokawa H; Nagayama M
Int J Oncol; 2003 Apr; 22(4):891-8. PubMed ID: 12632084
[TBL] [Abstract][Full Text] [Related]
8. [Effect of transcriptional factor snail on epithelial-mesenchymal transition and tumor metastasis].
Zhang AL; Wang QS; Zhong YH; Chen G; Xi L; Xie CH; Zhou YF; Ma D
Ai Zheng; 2005 Nov; 24(11):1301-5. PubMed ID: 16552952
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
10. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
[TBL] [Abstract][Full Text] [Related]
11. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.
Moreno-Bueno G; Cubillo E; Sarrió D; Peinado H; Rodríguez-Pinilla SM; Villa S; Bolós V; Jordá M; Fabra A; Portillo F; Palacios J; Cano A
Cancer Res; 2006 Oct; 66(19):9543-56. PubMed ID: 17018611
[TBL] [Abstract][Full Text] [Related]
12. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
13. Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK-3β-Dependent Mechanism.
Shyu HY; Ko CJ; Luo YC; Lin HY; Wu SR; Lan SW; Cheng TS; Hu SH; Lee MS
J Cell Biochem; 2016 Apr; 117(4):881-93. PubMed ID: 26365534
[TBL] [Abstract][Full Text] [Related]
14. Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.
Maeng YI; Kim KH; Kim JY; Lee SJ; Sung WJ; Lee CK; Park JB; Park KK
Int J Clin Exp Pathol; 2014; 7(7):4095-103. PubMed ID: 25120788
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.
Wels C; Joshi S; Koefinger P; Bergler H; Schaider H
J Invest Dermatol; 2011 Sep; 131(9):1877-85. PubMed ID: 21593765
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells.
Taki M; Verschueren K; Yokoyama K; Nagayama M; Kamata N
Int J Oncol; 2006 Feb; 28(2):487-96. PubMed ID: 16391805
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor Snail expressed in cutaneous squamous cell carcinoma induces epithelial-mesenchymal transition and down-regulates COX-2.
Shimokawa M; Haraguchi M; Kobayashi W; Higashi Y; Matsushita S; Kawai K; Kanekura T; Ozawa M
Biochem Biophys Res Commun; 2013 Jan; 430(3):1078-82. PubMed ID: 23261444
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer.
Hara J; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Oncol Rep; 2014 Feb; 31(2):589-96. PubMed ID: 24297447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
